A primer set for identifying Brucella and its detection method and application
By designing specific primer sets and optimizing PCR conditions, the accurate identification of Brucella, Brucella, and vaccine strain A19 of cattle, sheep, pig breeds was achieved, and the distinction between Brucella and vaccine strain A19 in the prior art was solved. The problem of the problem improves the specificity and sensitivity of the detection.
Patent Information
- Application Number
- CN202311306112.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-10-10
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2043-10-10
AI Technical Summary
The existing Brucella detection methods cannot effectively distinguish different types of Brucella, especially Brucella, cattle, sheep, and pig breeds and vaccine strain A19, and there is a problem of distinguishing between immune animals and naturally infected animals. The existing Multiple PCR method was not completely differentiated from the subtypes of Brucella bovine.
A specific, sensitive and fast multiplex PCR method was designed to perform multiplex PCR reactions using specific primer sets (including IS711, S, M, EA-F, EA-R, IA19-F, IA19-R) through expansion Fragments of different lengths (846bp, 501bp, 399bp, 618bp, 331bp) were increased to identify different types of Brucella, and primer concentration and PCR conditions were optimized to improve the specificity and sensitivity of the method.
Accurate identification of Brucella, cattle, sheep, pig breeds and vaccine strain A19, with high specificity and repeatability, can be detected at a sensitivity of 10copies/μL, and clinically associated with E. coli, Staphylococcus aureus, etc. Common bacteria have no cross-reactions.
Smart Images

Figure CN117106940B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of pathogen detection methods, and in particular to a primer set for identifying Brucella and a detection method and application thereof. Background Art
[0002] Brucella is a Gram-negative, non-motile bacterium with no capsule (smooth type has microcapsule), catalase and oxidase positive, an absolute aerobe, capable of reducing nitrates, and an intracellular parasite that can survive in many types of livestock.
[0003] Brucella can be divided into mestizonal Brucella, bovine Brucella, suis Brucella and canine Brucella according to the infected animals, antigen content and gene structure. Among them, mestizonal Brucella is the most pathogenic. The main species prevalent in my country is mestizonal Brucella, followed by bovine Brucella.
[0004] Brucella infection can cause brucellosis, with symptoms such as fever, fatigue, sweating, joint pain, testicular swelling and pain. If the infection is not treated in time, it can cause damage to large joints, peripheral neuritis, meningitis, and even complications such as thrombocytopenia, endocarditis, and glomerulonephritis, endangering the patient's life. Brucella that can make people sick mainly comes from animals infected with Brucella. Currently, more than 60 species of livestock, poultry, and wild animals can spread Brucella. The sources of infection closely related to human life are mainly sheep, cattle, and pigs infected with Brucella, followed by dogs, deer, horses, and camels. After animals are infected with Brucella, they first spread among the same species and then spread to humans.
[0005] In recent years, my country's animal husbandry has developed rapidly, and the number of large-scale farms has increased day by day. At present, my country's brucellosis prevention and control mainly implements comprehensive prevention and control measures of "mainly implementing continuous immunization in immune areas and mainly implementing continuous monitoring and elimination in non-immune areas". The vaccine commonly used in brucellosis immune areas is mainly Brucella attenuated A19 vaccine, but there are still many problems in the use of vaccines. Among them, the lack of relevant technical methods to distinguish immune animals from naturally infected animals is a major problem facing vaccine immunization.
[0006] At present, the multiplex PCR method based on the IS711 gene for distinguishing different types of Brucella cannot fully identify the eight subtypes of bovine Brucella and can only detect types 1, 2, and 4. Summary of the invention
[0007] In order to establish a method for simultaneously distinguishing different types of Brucella, the present invention provides a primer set for identifying different Brucella and a detection method and application thereof. The present invention provides a primer set for identifying Brucella and establishes a specific, sensitive and rapid multiplex PCR method, which can be used for the detection and identification of Brucella of bovine, ovine and porcine species and vaccine strain A19.
[0008] The present invention provides a primer set for identifying different Brucella species, the primer set comprising primer IS711, primer S, primer M, primer EA-F, primer EA-R, primer IA19-F and primer IA19-R;
[0009] The nucleotide sequence of the primer IS711 is shown in SEQ ID NO.1;
[0010] The nucleotide sequence of the primer S is shown in SEQ ID NO.2;
[0011] The nucleotide sequence of the primer M is shown in SEQ ID NO.3;
[0012] The nucleotide sequence of the primer EA-F is shown in SEQ ID NO.4;
[0013] The nucleotide sequence of the primer EA-R is shown in SEQ ID NO.5;
[0014] The nucleotide sequence of the primer IA19-F is shown in SEQ ID NO.6;
[0015] The nucleotide sequence of the primer IA19-R is shown in SEQ ID NO.7.
[0016] The present invention also provides an application of the primer set, wherein the application is selected from any one of the following:
[0017] (1) Identify or assist in identifying whether the bacteria to be tested are Brucella;
[0018] (2) preparing a test kit for identifying or assisting in identifying whether the bacterium to be tested is Brucella;
[0019] (3) Detecting whether the sample to be tested contains Brucella;
[0020] (4) preparing a test kit for detecting whether a sample to be tested contains Brucella;
[0021] The application is a non-disease diagnosis application.
[0022] The present invention also provides a kit containing the primer set, and the use of the kit is selected from any one of the following:
[0023] (1) Identify or assist in identifying whether the bacteria to be tested are Brucella;
[0024] (2) Detecting whether the sample to be tested contains Brucella;
[0025] The above uses are non-disease diagnosis applications.
[0026] Further, the kit includes a primer set, Bst DNA polymerase, a reaction buffer containing dNTPs and deionized water;
[0027] Wherein, the reaction buffer containing dNTPs comprises Tris-HCl, KC1, (NH4)2S04, MgS04, Tween 20 and dNTPs.
[0028] Furthermore, the Brucella is a wild strain of Brucella bovis, Brucella suis, Brucella melitensis or Brucella bovis A19 vaccine strain.
[0029] The present invention also provides a method for identifying or assisting in identifying whether a sample to be tested is Brucella, comprising the following steps: extracting DNA of the sample to be tested as a template, performing a multiplex PCR reaction with the primer set as a primer, and identifying the sample as Brucella suis S2 if fragments with lengths of 846 bp, 501 bp and 399 bp are amplified at the same time; identifying the sample as Brucella melitensis 16M if fragments with lengths of 618 bp, 501 bp and 399 bp are amplified at the same time; identifying the sample as Brucella bovis 2308 if only a fragment with length of 399 bp can be amplified; and identifying the sample as Brucella bovis A19 if only a fragment with length of 331 bp can be amplified.
[0030] The method described is for non-diagnostic use.
[0031] Furthermore, the nucleotide sequence of the 846 bp fragment is shown in SEQ ID NO.8;
[0032] The nucleotide sequence of the 501 bp fragment is shown in SEQ ID NO.10;
[0033] The nucleotide sequence of the fragment with a length of 399 bp is shown in SEQ ID NO.11.
[0034] Furthermore, the nucleotide sequence of the 618 bp fragment is shown in SEQ ID NO.9.
[0035] Furthermore, the nucleotide sequence of the 331 bp fragment is shown in SEQ ID NO.12.
[0036] Furthermore, the PCR reaction conditions were as follows: pre-denaturation at 94°C for 2 min, denaturation at 94°C for 30 s, annealing at 58°C for 30 s, 35 cycles; extension at 68°C for 50 s, and final extension at 72°C for 5 min.
[0037] Furthermore, the primer concentration in the multiplex PCR reaction is 2.5 μmol / L.
[0038] Compared with the prior art, the present invention has the following beneficial effects:
[0039] 1. The present invention provides a primer set for identifying Brucella and establishes a specific, sensitive and rapid multiplex PCR method that can be used for the detection and identification of Brucella of bovine, ovine and porcine species and vaccine strain A19.
[0040] 2. According to the gene sequences of bovine, ovine, suis Brucella and A19 vaccine strain obtained from GenBank, the present invention compared and found that the A19 vaccine strain lacked 68 bases in the ABC transport permease protein gene, the OMP31 gene was missing in bovine Brucella, and the copy number and position of IS711 in ovine and suis Brucella were different; NCBI Primer-BLAST was used to design 4 pairs of primers, and suis Brucella could amplify target fragments of 846 bp, 501 bp and 399 bp in size, and melitensis Brucella could amplify target fragments of 618 bp, 501 bp and 399 bp in size, and bovine Brucella wild strain could amplify 3 The target fragment of 99bp in size, A19 vaccine strain can amplify the target band of 331bp in size; the optimal primer concentration was determined to be 2.5μmol / L; the final optimized quadruple PCR reaction conditions were: 94℃2min; 94℃30s, 58℃30s, 68℃50s (35cycles); 72℃5min; there was no cross reaction with common clinical bacteria such as Escherichia coli, Staphylococcus aureus and Streptococcus ovis, and the repeated results were consistent, indicating that the method has strong specificity and good repeatability; sensitivity detection showed that bovine, ovine, swine Brucella and A19 vaccine strain all reached 10copies / μL, indicating that the method has high sensitivity. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0042] Figure 1 It is agarose gel electrophoresis of single-pair primer PCR; in the figure, the meanings of different lanes are, M: DL1000 DNAMarker; 1: blank control; 2: Brucella suis S2; 3: Brucella melitensis 16M; 4: Brucella suis S2; 5: Brucella melitensis 16M; 6: Brucella suis S2; 7: Brucella melitensis 16M; 8: Brucella bovis 2308; 9: Brucella bovis A19.
[0043] Figure 2Agarose gel electrophoresis of pMD-19T-S; M: DL1000 DNA Marker; 1: negative control; 2, 3, 4: PCR products of the recombinant vector pMD-19T-S.
[0044] Figure 3 Agarose gel electrophoresis of pMD-19T-M; M: DL1000 DNA Marker; 1: negative control; 2, 3, 4: PCR products of the recombinant vector pMD-19T-M.
[0045] Figure 4 Agarose gel electrophoresis of pMD-19T-EA; M: DL1000 DNA Marker; 1: negative control; 2, 3, 4: PCR products of Brucella suis S2 recombinant vector pMD-19T-EA; 5, 6, 7: PCR products of Brucella melitensis 16M recombinant vector pMD-19T-EA.
[0046] Figure 5 Agarose gel electrophoresis of pMD-19T-IB / IA19; M: DL1000 DNA Marker; 1: negative control; M: DL1000 DNA Marker; 1: negative control; 2, 3, 4: PCR products of the recombinant vector pMD-19T-IB of Brucella suis S2; 5, 6, 7: PCR products of the recombinant vector pMD-19T-IB of Brucella melitensis 16M; 8, 9, 10: PCR products of the recombinant vector pMD-19T-IB of Brucella bovis 2308; 11, 12, 13: PCR products of the recombinant vector pMD-19T-IA19 of Brucella bovis A19.
[0047] Figure 6 PCR specific identification of primer IS711 / S; M: DL1000 DNA Marker; 1: negative control; 2: Brucella suis S2; 3: Brucella melitensis 16M; 4: Brucella bovis 2308; 5: Brucella bovis A19; 6: Escherichia coli; 7: Staphylococcus aureus; 8: Streptococcus capitis.
[0048] Figure 7 is the PCR specificity of primer IS711 / M; M: DL1000 DNA Marker; 1: negative control; 2: Brucella melitensis 16M; 3: Brucella suis S2; 4: Brucella bovis 2308; 5: Brucella bovis A19; 6: Escherichia coli; 7: Staphylococcus aureus; 8: Streptococcus capitis.
[0049] Figure 8is the PCR specificity of primer EA-F / R; M: DL1000 DNA Marker; 1: negative control; 2: Brucella suis S2; 3: Brucella melitensis 16M; 4: Brucella bovis 2308; 5: Brucella bovis A19; 6: Escherichia coli; 7: Staphylococcus aureus; 8: Streptococcus capitis.
[0050] Fig. 9 is the PCR specificity of primer IA19-F / R; M: DL1000 DNA Marker; 1: negative control; 2: Brucella melitensis 16M; 3: Brucella suis S2; 4: Brucella bovis 2308; 5: Brucella bovis A19; 6: Escherichia coli; 7: Staphylococcus aureus; 8: Streptococcus capitis.
[0051] Fig.10 Agarose gel electrophoresis of multiple primer PCR; M: DL1000 DNA Marker; 1: blank control; 2: Brucella suis S2; 3: Brucella melitensis 16M; 4: Brucella bovis 2308; 5: Brucella bovis A19.
[0052] Fig.11 The amplification of pMD-19T-S plasmid with primer IS711 / S of different concentrations; M: DL1000 DNA Marker; 1: negative control; 2-9: primer concentrations are 0.1, 0.25, 0.5, 1.0, 2.5, 5.0, 7.5, and 10.0 μmol / L, respectively.
[0053] Fig.12 This is the amplification of pMD-19T-M plasmid with primer IS711 / M at different concentrations; M: DL1000 DNA Marker; 1: negative control; Lanes 2 to 9: primer concentrations are 0.1, 0.25, 0.5, 1.0, 2.5, 5.0, 7.5, and 10.0 μmol / L, respectively.
[0054] Fig.13 Amplification of pMD-19T-EA plasmid with primers EA-F / R of different concentrations; M: DL1000 DNA Marker; 1: negative control; Lanes 2 to 9: primer concentrations are 0.1, 0.25, 0.5, 1.0, 2.5, 5.0, 7.5, and 10.0 μmol / L, respectively.
[0055] Fig.14 Amplification of pMD-19T-IB plasmid with primers IA-F / R of different concentrations; M: DL1000 DNA Marker; 1: negative control; Lanes 2 to 9: primer concentrations are 0.1, 0.25, 0.5, 1.0, 2.5, 5.0, 7.5, and 10.0 μmol / L, respectively.
[0056] Fig.15 Amplification of pMD-19T-IA19 plasmid with primers IA-F / R of different concentrations; M: DL1000 DNA Marker; 1: negative control; Lanes 2 to 9: primer concentrations are 0.1, 0.25, 0.5, 1.0, 2.5, 5.0, 7.5, and 10.0 μmol / L, respectively.
[0057] Fig.16 The effect of different annealing temperatures on multiplex PCR; the meaning of each lane is: M: DL1000 DNA Marker; 1: negative control; 2, 6, 10, 14, 18: the annealing temperatures of Brucella suis S2 are 56℃, 58℃, 60℃, 62℃, 64℃ respectively; 3, 7, 11, 15, 19: the annealing temperatures of Brucella melitensis 16M are 56℃, 58℃, 60℃, 62℃, 64℃ respectively; 4, 8, 12, 16, 20: the annealing temperatures of Brucella bovis 2308 are 56℃, 58℃, 60℃, 62℃, 64℃ respectively; 5, 9, 13, 17, 21: the annealing temperatures of Brucella bovis A19 are 56℃, 58℃, 60℃, 62℃, 64℃ respectively.
[0058] Fig.17 The effect of different cycle numbers on multiplex PCR; the meaning of each lane is: M: DL1000DNA Marker; Lane 1: negative control; Lanes 2, 6, 10: the cycle numbers of Brucella suis S2 are 25, 30, and 35 cycles respectively; Lanes 3, 7, 11: the cycle numbers of Brucella melitensis 16M are 25, 30, and 35 cycles respectively; Lanes 4, 8, 12: the cycle numbers of Brucella bovis S2308 are 25, 30, and 35 cycles respectively; Lanes 5, 9, 13: the cycle numbers of Brucella bovis A19 are 25, 30, and 35 cycles respectively.
[0059] Fig.18 The effect of different annealing times on multiplex PCR; the meaning of each lane is: M: DL1000 DNA Marker; Lane 1: negative control; Lanes 2, 6, 10: annealing time of Brucella suis S2 is 20s, 30s, and 40s respectively; Lanes 3, 7, 11: annealing time of Brucella melitensis 16M is 20s, 30s, and 40s respectively; Lanes 4, 8, 12: annealing time of Brucella bovis S2308 is 20s, 30s, and 40s respectively; Lanes 5, 9, 13: annealing time of Brucella bovis A19 is 20s, 30s, and 40s respectively.
[0060] Fig.19The effect of different extension time on multiplex PCR; the meaning of each lane is: M: DL1000 DNA Marker; 1: negative control; Lanes 2, 6, 10: annealing temperatures of Brucella suis S2 are 40s, 50s, and 60s respectively; Lanes 3, 7, 11: annealing temperatures of Brucella melitensis 16M are 40s, 50s, and 60s respectively; Lanes 4, 8, 12: annealing temperatures of Brucella bovis S2308 are 40s, 50s, and 60s respectively; Lanes 5, 9, 13: annealing temperatures of Brucella bovis A19 are 40s, 50s, and 60s respectively.
[0061] Fig. 20 It is the specific detection of multiplex PCR; the meaning of each lane is: Lane M: DL1000 DNA Marker; Lane 1: negative control; Lane 2: Brucella suis S2; Lane 3: Brucella melitensis 16M; Lane 4: Brucella bovis 2308; Lane 5: Brucella bovis A19; Lane 6: Escherichia coli; Lane 7: Staphylococcus aureus; Lane 8: Streptococcus capitis.
[0062] Fig.21 It is the Nde I restriction enzyme digestion identification of the recombinant plasmid; the meaning of each lane is: Lane M: DL5000DNA Marker; Lane 1: negative control; Lane 2: recombinant plasmid pMD-19T-S; Lane 3: recombinant plasmid pMD-19T-M; Lane 4: recombinant plasmid pMD-19T-EA; Lane 5: recombinant plasmid pMD-19T-IB; Lane 6: recombinant plasmid pMD-19T-IA19.
[0063] Fig. 22 It is the sensitivity of multiplex PCR detection of IS711 gene of Brucella suis S2; the meaning of each lane is: Lane M: DL1000 DNA Marker; Lanes 1-6: Copy concentration of IS711 gene of Brucella suis S2: 1copies / μL, 5copies / μL, 10copies / μL, 20copies / μL, 50copies / μL, 100copies / μL; Lane 7: negative control.
[0064] Fig.23 It is the sensitivity of multiplex PCR detection of Brucella melitensis 16M regarding IS711 gene; the meaning of each lane is: Lane M: DL1000 DNA Marker; Lanes 1 to 6: The copy concentrations of Brucella melitensis 16M regarding IS711 gene are: 1copies / μL, 5copies / μL, 10copies / μL, 20copies / μL, 50copies / μL, 100copies / μL respectively; 7: negative control.
[0065] Fig.24 It is the sensitivity of multiplex PCR detection of OMP31 gene; the meaning of each lane is: Lane M: DL1000 DNAMarker; Lanes 1 to 6: the copy concentrations of OMP31 gene are 1copies / μL, 5copies / μL, 10copies / μL, 20copies / μL, 50copies / μL, 100copies / μL respectively; 7: negative control.
[0066] Fig.25 It is the sensitivity of multiplex PCR detection of ABC transporter permease gene in Brucella bovis 2308; the meaning of each lane is: M: DL1000 DNA Marker; Lanes 1 to 6: copy concentration of ABC transporter permease gene in Brucella bovis 2308: 1copies / μL, 5copies / μL, 10copies / μL, 20copies / μL, 50copies / μL, 100copies / μL; 7: negative control.
[0067] Fig.26 It is the sensitivity of multiplex PCR detection of ABC transporter permease gene of Brucella bovis A19; the meaning of each lane is: Lane M: DL1000 DNA Marker; Lanes 1-6: Copy concentrations of ABC transporter permease gene of Brucella bovis A19: 1copies / μL, 5copies / μL, 10copies / μL, 20copies / μL, 50copies / μL, 100copies / μL; 7: negative control.
[0068] Fig. 27 This is the repeatability test of Brucella suis S2 by multiplex PCR; M: DL1000 DNA Marker; 1: negative control; 2, 3, 4: Brucella suis S2.
[0069] Fig.28 This is the repeatability test of multiplex PCR on Brucella melitensis 16M; M: DL1000 DNA Marker; 1: negative control; 2, 3, 4: Brucella melitensis 16M.
[0070] Fig.29 This is the repeatability test of multiplex PCR on Brucella bovis 2308; M: DL1000 DNA Marker; 1: negative control; 2, 3, 4: Brucella bovis 2308.
[0071] Fig.30This is the repeatability test of multiplex PCR for Brucella bovis A19; M: DL1000 DNA Marker; 1: negative control; 2, 3, 4: Brucella bovis A19. DETAILED DESCRIPTION
[0072] The specific embodiments of the present invention are described in detail below, but it should be understood that the protection scope of the present invention is not limited by the specific embodiments. Based on the embodiments in the present invention, all other embodiments obtained by ordinary technicians in this field without creative work belong to the scope of protection of the present invention. The experimental methods described in the embodiments of the present invention are conventional methods unless otherwise specified, and the materials, reagents, etc. used in the following embodiments can be obtained from commercial channels unless otherwise specified.
[0073] The present invention compares the gene sequences of bovine, ovine, suis Brucella and A19 vaccine strain obtained from GenBank, and finds that the A19 vaccine strain lacks 68 bases in the ABC transport permease protein gene, the OMP31 gene is missing in bovine Brucella, and the copy number and position of IS711 in ovine and suis Brucella are different; NCBI Primer-BLAST is used to design 4 pairs of primers, and the target fragments of 846 bp, 501 bp and 399 bp in size can be amplified for suis Brucella, the target fragments of 618 bp, 501 bp and 399 bp in size can be amplified for melitensis Brucella, and the wild strain of bovine Brucella can amplify 39 The target fragment of 9bp in size, A19 vaccine strain can amplify the target band of 331bp in size; the optimal primer concentration was determined to be 2.5μmol / L; the final optimized quadruple PCR reaction conditions were: 94℃2min; 94℃30s, 58℃30s, 68℃50s (35cycles); 72℃5min; it showed no cross reaction with common clinical bacteria such as Escherichia coli, Staphylococcus aureus and Streptococcus ovis, and the repeated results were consistent, indicating that the method has strong specificity and good repeatability; sensitivity detection showed that Brucella bovis, sheep and porcine species and A19 vaccine strain all reached 10copies / μL, indicating that the method has high sensitivity.
[0074] Example 1: A primer set for identifying Brucella and its detection method and application.
[0075] 1. Experimental Materials and Methods
[0076] 1. Strains and samples
[0077] Brucella abortus A19, Brucella suis S2, Brucella melitensis 16M, Brucella abortus 2308, Staphylococcus aureus, Escherichia coli, Streptococcus ovis.
[0078] 2. Primer design for multiplex PCR
[0079] According to the gene sequences of Brucella bovis (NC_007624.1), Brucella melitensis (CP007763.1, CP007762.1), Brucella suis (CP006961.1, CP006962.1), and Brucella bovis A19 (CP030752.1) registered in GenBank, bioinformatics analysis was first performed, and four pairs of primers were designed using NCBI Primer BLAST (Table 1) based on the deletion of 68 bases in the ABC transporter permease gene (WP_002965788.1) of Brucella bovis A19, the deletion of the OMP31 gene (FJ984569) in Brucella bovis, and the differences in the copy number and position of the IS711 gene (ON094065.1, KT309077.1) of Brucella melitensis and Brucella suis. The primers were synthesized by Beijing Qingke Company.
[0080] Table 1 Primer information
[0081]
[0082] 3. Acquisition and preservation of bacterial genomes
[0083] The glycerol-frozen bacterial liquid of B. abortus A19 and B. suis S2 was streaked on a TSA culture dish for resuscitation, cultured at 37°C for 48 hours, and a single colony was picked and inoculated into a centrifuge tube containing 5 mL of TSB liquid culture medium, and cultured overnight at 37°C and 300 r / min. 1 mL of bacterial liquid was taken into a 2 mL centrifuge tube, and the bacterial genomic DNA was extracted and purified, and the extracted DNA was stored at -20°C for later use. The bacterial genomic DNA of B. melitensis 16M and B. abortus 2308 was directly extracted and purified, and the extracted DNA was stored at -20°C for later use.
[0084] 4. PCR amplification with a single pair of primers
[0085] According to the different sizes of the target fragments amplified by the four pairs of primers, primer IS711 / S, primer EA-F / R and primer IA19-F / R were used to amplify the DNA of B.suis S2, primer IS711 / M, primer EA-F / R and primer IA19-F / R were used to amplify the DNA of B.melitensis 16M, primer IA19-F / R was used to amplify the DNA of B.abortus 2308; primer IA19-F / R was used to amplify the DNA of B.abortus A19. The initial PCR amplification conditions are shown in Table 2: 94℃2min; 94℃30s, 58℃30s, 68℃55s (30cycles); 72℃5min. Finally, 1.5% agarose gel electrophoresis test was performed for identification.
[0086] Table 2 Reaction system
[0087] Element volume Quick Taq Hs DyeMix 10μL 4 pairs of primer mixture (2.5μmol / L) 4μL DNA template 1μL Ultrapure water 5μL total 20μL
[0088] 5. Construction of recombinant plasmid
[0089] The target fragments amplified by PCR with a single pair of primers of four Brucella strains, B.suis S2, B.melitensis 16M, B.abortus 2308 and B.abortus A19, were recovered, and then the recovered target fragments were connected to the pMD-19T vector. The recombinant vector was transformed to construct a recombinant plasmid, and the recombinant plasmid was extracted for PCR identification to verify whether the connection was successful, and finally a 1.5% agarose gel electrophoresis test was performed for identification.
[0090] The recombinant plasmids successfully identified by PCR were sent for testing to determine whether the amplified sequence was consistent with the expected design, and the sequencing results were compared using NCBI Blast.
[0091] 6. Specificity of single primer pair PCR
[0092] The genomic DNA of B.suis S2, B.melitensis 16M, B.abortus 2308, B.abortus A19, Escherichia coli, Staphylococcus aureus, and Streptococcus capitis were used as templates and amplified according to the initial PCR reaction conditions. The specificity of the single-pair primer PCR was verified respectively.
[0093] 7. Establishment of multiplex PCR reaction
[0094] The genomic DNA of B.suis S2, B.melitensis 16M, B.abortus 2308 and B.abortus A19 were used as templates, four pairs of primers were added to the PCR reaction system at the same time, and amplification was performed according to the initial PCR reaction conditions. Finally, 1.5% agarose gel electrophoresis test was performed for identification.
[0095] 8. Optimization of multiplex PCR reactions
[0096] (1) Optimization of primer concentration
[0097] Primer concentration is crucial for the establishment of multiplex PCR methods. Therefore, different gradient primer concentrations were set for identification, namely: 0.1, 0.25, 0.5, 1.0, 2.5, 5.0, 7.5 and 10.0 μmol / L, and then the concentrations of the four primers were optimized using the extracted recombinant plasmid DNA. Finally, a 1.5% agarose gel electrophoresis test was performed to determine the optimal primer concentration based on the identification results.
[0098] (2) Optimization of multiplex PCR reaction conditions
[0099] The annealing temperature, number of cycles, annealing time and extension time in the PCR reaction conditions were optimized respectively. First, the annealing temperatures of different gradients were set with a difference of 2°C, which were 56°C, 58°C, 60°C, 62°C, and 64°C. Secondly, the number of cycles of three different gradients was set, which were 25 cycles, 30 cycles, and 35 cycles. The annealing time of three different gradients was set to 20s, 30s, and 40s. The extension time will also have a certain impact on the results of the multiple PCR reaction, so the extension time of three different gradients was set to 45s, 50s, and 55s. Finally, a 1.5% agarose gel electrophoresis test was performed to determine the optimal reaction conditions.
[0100] 9. Specificity of multiplex PCR reactions
[0101] The genomic DNA of B. suis S2, B. melitensis 16M, B. abortus 2308, B. abortus A19, Escherichia coli, Staphylococcus aureus, and Streptococcus capitis were amplified by multiplex PCR to verify the specificity of the multiplex PCR reaction.
[0102] 10. Sensitivity of multiplex PCR reactions
[0103] First, the four recombinant plasmids were identified by single enzyme digestion; then the concentrations of the four recombinant plasmids were converted to the target gene copy number according to the following formula, and then the four recombinant plasmids were diluted with ddH2O in multiples to make the target gene copy concentrations 1, 5, 10, 20, 50 and 100 copies / μL, and used as templates for PCR reactions, and finally 1.5% agarose gel electrophoresis test was performed to verify the sensitivity of multiplex PCR. The lower the detected copy concentration, the higher the sensitivity.
[0104] (6.02×10 23 )×(ng / μL×10 -9 ) / (DNA length×660)=copies / μL
[0105] Where ng / μL is the concentration of the recombinant plasmid solution, and copies / μL represents the copy concentration of the target gene.
[0106] 11. Repeatability of multiplex PCR reactions
[0107] The genomic DNA of B. suis S2, B. melitensis 16M, B. abortus 2308 and B. abortus A19 were used as templates, and the operation of multiplex PCR reaction was repeated three times to verify the repeatability of the multiplex PCR method.
[0108] 2. Experimental Results
[0109] 1. PCR amplification with a single pair of primers
[0110] The designed four pairs of primers were used to perform PCR amplification on the DNA of B.suis S2, B.melitensis 16M, B.abortus2308, and B.abortus A19, respectively. The reaction system is shown in Table 2. The sizes of the fragments amplified by B.suis S2 were 846 bp (nucleotide sequence as shown in SEQ ID NO.8), 501 bp (nucleotide sequence as shown in SEQ ID NO.10), and 399 bp (nucleotide sequence as shown in SEQ ID NO.11), the sizes of the fragments amplified by B.melitensis 16M were 618 bp (nucleotide sequence as shown in SEQ ID NO.9), 501 bp (nucleotide sequence as shown in SEQ ID NO.10), and 399 bp (nucleotide sequence as shown in SEQ ID NO.11), the size of the fragments amplified by B.abortus 2308 was 399 bp (nucleotide sequence as shown in SEQ ID NO.11), and the size of the fragments amplified by B.abortus A19 was 331 bp (nucleotide sequence as shown in SEQ ID NO.12). The results are shown in Table 2. Figure 1 As shown, the amplified target bands are all consistent with the expectations.
[0111] SEQ ID NO.8:
[0112] CGATTTCGGCAATGAGCTGGCCTTGTTTGACGTGATCGCCCACTTCCACCTTCACGCTTTTCAACTGGCCGGAAACCTGCGCGCCAACGTTGACGCTGCGCAATGCGCTCAGCGTGCCGACGGCGGTGATGGCGTTTTCGATGTCACCACGGGTGACAGTCTCCGCAAGATAGCTGCTCTTCTCGCCGTCAGCCTTATAAGAGCCGTAGAAGTACCAGCCCGCGCCGATGATGATGGCGGCGGCTGAAAGCCAGAGCCACCAGCGGCGCTTTCCTTTGGCGCGTTTGCGGGCCGATGCCGGTTGCTGGCCTAATTGAGAAGAATCACTAGATTTAAGCACCCTAGGGCTTGTCTGCATTCAAGGATTCCCTTTTGCATGAAATTCTGATTCAAGGTTGTTGAAGGAGAACAGCCGTGAGCAGACGAAGCCTTACAGATGAGCAATGGAACCGGATCGAAGCATATCTTCCGGGGCGAGTTGGTACGCCCGGCCGCAGTGGCGTTGATAACCGATTATTTGTCGACGCCATCTTGTGGATGGCTGCCAATGCAGCGCACTGGCGCGATCTGCCTGCGACCTTCGGCAAATGGACAGCGGTTCATGCCCGCTTTCGGCGATGGTCGCACGCCGGTGTATGGGGAAGGCTTTTCCATGCCCTGGCTGATACGCCGGACTTTGAATATGTCCTCATTGATAGCACCATATCGAAAGTCCACGCAGATGCGGCGGGCGCAAAAGGGGGGCTGAAGCTGCCTGCATCGGTCGCTCGCGCGGTGGATTGACGACCAAGCTGCATGCTGTTGTCGATGCTATCGGCCTACCGCTGCGAATAAAGCCAACACCCG
[0113] SEQ ID NO.9:
[0114] CCGGCGAGTTATCCACAAGTCTCGACGATACACCAGCATGACCGATATACTTATAGCTTGCAGCGGTATTAATTTCGCGTCGGGGTAAAAATGGACAGCGATTCGAGGTTGGTTTAGGGCCTGTCTGCATTCAAGGATTCCCTTTTGTACGAAATTCTGATTCAAGGTTGTTAAAGGAGAACAGCCGTGAGCAGACGAAGCTTTACAGATGAGCAATGGAACCGGATCGAAGCATATCTTCCGGGGCGAGTTGGTACGCCCGGCCGCAGTGGCGTTGATAACCGATTATTTGTCGACGCCATCTTGTGGATGGCTGCCAATGCAGCGCACTGGCGCGATCTGCCTGCGACCTTCGGCAAATGGACAGCGGTTCATGCCCGCTTTCGGCGCTGGTCGCACGCCGGTGTATGGGAAAGGCTTTTCCATGCCCTGGCTGATACGCCGGACTTTGAATATGTCCTCATTGACAGCACCATATCGAAAGTCCACGCAGATGCGGCGGGCGCAAAAGGGGGGCTGAAGCTGCCTGCATCGGTCGCTCGCGCGGGGGATTGACGACCAAGCTGCATGCTGTTGTCGATGCTATCGGCCTACCGCTGCGAATAAAGCCAACACCCG
[0115] SEQ ID NO.10:
[0116] CGCGAACAGTGTGGAAATTGACCTTGCTCTCAAGGAAGCTATTGTCAACGTCGACGAGGTTGCGCTTGCCGAGGTCGGTGTAGAGGTATTCCGACTTGAGCGTCCAGTTGTTGTTGATGGCATATTCAGCACCAGCGCCGAGGGTCCAGCCAGCTTTCGTCTTGTCGGACCACGTGTGCAGGGCACTTGCATCATCACCCAGGTTGAACGCAGACTTGACCTTACCATAGGCCAGACCGCCGGTACCATAAACCATGAGGCGTTCGGTAGCCGTGTAGCCAAGACGGGCACGAACTGTGCCGAACCACTCGACCTTGGTTTCAGCTTTGCCTTCGAGACCGCTGGCACCGGCTGAAATCGAACCCGTAACGCTCGATCCCTGGAAGTCGGTTTCCGCGCCGAGCACGACGCCGTTGTCGAGCTGCCAGTTGTAACCGGCCTGAACACCACCGACGAAGCCGCCAGCTGTTACGTCGAGCGAACCGGAAACCTGTTCGTTGT
[0117] SEQ ID NO.11:
[0118] CTTCTCGTTCCTTTCGCCCTATTACTTTACGGTCGATAATTTCCTCATCATGTCGTCGCATGTGGCCATTTTCGGCCTTCTGGCGATTGGTATGCTGCTCGTCATCCTCAATGGCGGCATCGACCTTTCGGTCGGCTCCACGCTGGGGCTGGCCGGTGTGGTCGCGGGCTTCCTGATGCAGGGCGTGACCTTGCAGGAATTCGGCATCATCCTTTATTTCCCGGTCTGGGCCGTGGTGCTCATCACCTGCGCGCTCGGCGCCTTCGTCGGCGCGGTCAATGGTGTGTTGATCGCTTATCTGCGCGTTCCGGCCTTCGTGGCGACGCTTGGCGTTCTTTATTGCGCGCGTGGCGTAGCGCTTTTGATGACCAACGGTCTCACCTACAACAATCTCGGCGG
[0119] SEQ ID NO.12:
[0120] CTTCTCGTTCCTTTCGCCCTATTACTTTACGGTCGATAATTTCCTCATCATGTCGTCGCATGTGGCCATTTTCGGCCTTCTGGCGATTGGTATGCTGCTCGTCATCCTCAATGGCGGCATCGACCTTTCGGTCGGCTCCACGCTGGGGCTGGCCGGTCTGGGCCG TGGTGCTCATCACCTGCGCGCTCGGCGCCTTCGTCGGCGCGGTCAATGGTGTGTTGATCGCTTATCTGCGCGTTCCGGCCTTCGTGGCGACGCTTGGCGTTCTTTATTGCGCGCGTGGCGTAGCGCTTTTGATGACCAACGGTCTCACCTACAACAATCTCGGCGG
[0121] 2. Construction of recombinant plasmid
[0122] The constructed plasmid was extracted and verified by single-pair primer PCR. The recombinant vectors showed 846 bp ( Figure 2 )、618bp( Figure 3 )、501bp( Figure 4 ), 399bp and 331bp ( Figure 5 ) bands, indicating that the recovered target fragments have been successfully connected to the pMD-19T vector, and the recombinant pMD-19T-S, pMD-19T-M, pMD-19T-EA, pMD-19T-IB, and pMD-19T-IA19 vectors have been successfully constructed. By using NCBI's Blast to compare the sequencing results, the results showed that the homology with the gene sequence registered in Genbank reached 100%, proving that the target fragment was successfully inserted.
[0123] 3. Specificity of single-pair primer PCR
[0124] The gel electrophoresis results showed that, in addition to the 846 bp ( Figure 6 ), B. melitensis16M amplified 618bp ( Figure 7 ), B.suis S2, B.melitensis 16M, B.abortus 2308 amplified 399 bp ( Figure 8 ), B. abortus A19 amplified 331 bp ( Fig. 9 ), no bands were amplified from the other three bacteria, indicating that the primers had good specificity.
[0125] 4. Establishment of multiplex PCR reaction
[0126] The gel electrophoresis results showed that the fragment sizes amplified by B.suis S2 were 846 bp, 501 bp and 399 bp, the fragment sizes amplified by B.melitensis 16M were 618 bp, 501 bp and 399 bp, the fragment size amplified by B.abortus 2308 was 399 bp, and the fragment size amplified by B.abortus A19 was 331 bp ( Fig.10 ), the amplified target bands were consistent with the expected design.
[0127] 5. Optimization of multiplex PCR reactions
[0128] (1) Optimization of primer concentration
[0129] The gel electrophoresis results showed that the target band appeared when the primer concentration was greater than 0.25 μmol / L, and no target band appeared when the primer concentration was less than 0.25 μmol / L (e.g. Figure 11-Figure 15 ). Comprehensively considering the observations, the primer concentration for the best PCR amplification effect was 2.5 μmol / L, so 2.5 μmol / L was determined as the optimal primer concentration for multiplex PCR reactions.
[0130] (2) Optimization of multiplex PCR reaction conditions
[0131] The different conditions of the PCR reaction were optimized. The results showed that when the annealing temperature was 56°C, the target band was not very clear, and too high an annealing temperature would affect the specific binding of the primer and the template. At 58°C, the target band of the amplified product was clearly visible ( Fig.16 ), so 58℃ was selected as the optimal annealing temperature. The results showed that the brightness of the amplified target band was clearer and brighter at 35 cycles, so 35 cycles were selected as the optimal number of cycles ( Fig.17 The results showed that different annealing time and extension time had little effect on the amplification efficiency of the PCR reaction ( Fig.18 , Fig.19 ), so the annealing time was determined to be 30s and the extension time was 50s after comprehensive consideration and evaluation. The optimal multiplex PCR reaction conditions are shown in Table 3.
[0132] Table 3 Multiplex PCR reaction conditions
[0133] step temperature time Cycle times Pre-denaturation 94℃ 2min transsexual 94℃ 30s annealing 58℃ 30s 35cycles extend 68℃ 50s Final extension 72℃ 5min
[0134] 6. Specificity of multiplex PCR reactions
[0135] The gel electrophoresis results showed that B.suis S2 could amplify 846bp, 501bp and 399bp simultaneously, B.melitensis16M could amplify 618bp, 501bp and 399bp simultaneously, B.abortus 2308 could amplify 399bp, and B.abortus A19 could amplify 331bp. The amplified target bands were consistent with the expected design, while the other three strains did not amplify any target bands ( Fig. 20 ), indicating that the method has good specificity and no cross-reaction with other common bacteria.
[0136] 7. Sensitivity of multiplex PCR reactions
[0137] The four recombinant plasmids that had been successfully sequenced were digested with Nde I and the results showed that each lane had only one target band, proving that the target gene template was only a single plasmid ( Fig.21 ); then convert the plasmid concentration to the target gene copy concentration, and dilute the target gene copy concentration to the following gradient: 1 copy / μL, 5 copies / μL, 10 copies / μL, 20 copies / μL, 50 copies / μL, 100 copies / μL. Figure 22 to Figure 26 It can be seen that all four plasmids showed faint bands in lane 3, so the sensitivity of the multiplex PCR method for detecting the four target genes reached 10 copies / μL.
[0138] 8. Repeatability of multiplex PCR reactions
[0139] B.suis S2( Fig. 27 )、B.melitensis 16M( Fig.28 )、B.abortus 2308( Fig.29 )、B.abortus A19( Fig.30 ) genomic DNA was tested three times, and the results showed that the target bands could be amplified and the band sizes were consistent with the expected design. No bands were amplified in the negative control, indicating that the method had good repeatability.
[0140] The present invention uses IS711 gene, OMP31 gene, ABC transporter permease gene to design primers, and optimizes the reaction conditions to establish a quadruple PCR detection method, which can simultaneously identify and detect bovine, ovine, swine Brucella and vaccine strain A19. Compared with other detection methods currently established for identifying different types of Brucella, the present invention has a wider detection coverage for various subtypes of bovine, ovine, and swine Brucella, and the detection method can identify vaccine strains and wild strains, with good specificity and high sensitivity.
[0141] Although the preferred embodiments of the present invention have been described, those skilled in the art may make other changes and modifications to these embodiments once they have learned the basic creative concept. Therefore, the appended claims are intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention.
[0142] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.
Claims
1. A primer set for identifying Brucella, It is characterized in that The primer set includes primer pair IS711 / S, primer pair EA-F / R, primer pair IA19-F / R and primer pair IS711 / M; The primer pair IS711 / S consists of primer IS711 and primer S, the primer pair EA-F / R consists of primer EA-F and primer EA-R, the primer pair IA19-F / R consists of primer IA19-F and primer IA19-R, and the primer pair IS711 / M consists of primer IS711 and primer M; The nucleotide sequence of the primer IS711 is shown in SEQ ID NO.1; The nucleotide sequence of the primer S is shown in SEQ ID NO.2; The nucleotide sequence of the primer M is shown in SEQ ID NO.3; The nucleotide sequence of the primer EA-F is shown in SEQ ID NO.4; The nucleotide sequence of the primer EA-R is shown in SEQ ID NO.5; The nucleotide sequence of the primer IA19-F is shown in SEQ ID NO.6; The nucleotide sequence of the primer IA19-R is shown in SEQ ID NO.
7.
2. An application of the primer set according to claim 1, wherein the application is selected from any one of the following: (1) Identify or assist in identifying whether the bacteria to be tested are Brucella; The Brucella is a wild strain of Brucella bovis 2308, Brucella suis S2, Brucella melitensis 16M or Brucella bovis A19 vaccine strain; (2) preparing a kit for identifying or assisting in identifying whether the bacteria to be tested are Brucella; (3) Detect whether the sample contains Brucella; (4) preparing a test kit for detecting whether a sample to be tested contains Brucella; The application is a non-disease diagnosis application.
3. A kit comprising the primer set according to claim 1, It is characterized in that The purpose of the kit is to select any one of the following: (1) Identify or assist in identifying whether the bacteria to be tested are Brucella; The Brucella is a wild strain of Brucella bovis 2308, Brucella suis S2, Brucella melitensis 16M or Brucella bovis A19 vaccine strain; (2) Detect whether the sample to be tested contains Brucella; The above uses are non-disease diagnosis applications.
4. A method for identifying or assisting in identifying whether a sample to be tested is Brucella, It is characterized in that The method comprises the following steps: extracting DNA of a sample to be tested as a template, carrying out a multiplex PCR reaction with the primer set described in claim 1 as a primer, and identifying the sample as Brucella suis S2 if fragments with lengths of 846 bp, 501 bp and 399 bp are amplified at the same time; identifying the sample as Brucella melitensis 16M if fragments with lengths of 618 bp, 501 bp and 399 bp are amplified at the same time; identifying the sample as Brucella bovis 2308 if only a fragment with length of 399 bp can be amplified; and identifying the sample as Brucella bovis A19 if only a fragment with length of 331 bp can be amplified. The method described is for non-diagnostic use.
5. The method according to claim 4 for identifying or assisting in identifying whether the sample to be tested is Brucella, It is characterized in that The nucleotide sequence of the 846 bp fragment is shown in SEQ ID NO.8; The nucleotide sequence of the 501 bp fragment is shown in SEQ ID NO.10; The nucleotide sequence of the 399 bp fragment is shown in SEQ ID NO.
11.
6. The method for identifying or assisting in identifying whether a sample to be tested is Brucella according to claim 5, It is characterized in that The nucleotide sequence of the 618 bp fragment is shown in SEQ ID NO.
9.
7. The method for identifying or assisting in identifying whether a sample to be tested is Brucella according to claim 6, It is characterized in that The nucleotide sequence of the fragment with a length of 331 bp is shown in SEQ ID NO.
12.
8. The method for identifying or assisting in identifying whether a sample to be tested is Brucella according to claim 4, It is characterized in that The PCR reaction conditions were as follows: pre-denaturation at 94°C for 2 min, denaturation at 94°C for 30 s, annealing at 58°C for 30 s, 35 cycles; extension at 68°C for 50 s, and final extension at 72°C for 5 min.
9. The method for identifying or assisting in identifying whether a sample to be tested is Brucella according to claim 4, It is characterized in that The primer concentration during the multiplex PCR reaction was 2.5 μmol / L.
Citation Information
Cited By
Primer composition and kit for identifying universal type and vaccine strain of brucella
CN120442824A
